Chondroblastoma of the patella, rare occurred in patellar,is a kind of an uncommon benign bone tumor. Compared with giant cell tumor, the morbidity of chondroblastoma is lower. Meanwhile, its clinical manifestations are various, and images are very complicated. Therefore, the understanding of this kind of tumors may be limited even to the orthopedist. The differences of patellar chondroblastoma between other tumor in X-ray, CT and MRI is a spot in recent years. Sometimes patellar chondroblastoma coexists with aneurysmal bone cyst, which is a challenge to obtain an accurate pathological and radiological diagnosis. For the treatment, curettage and bone grafting is one the most popular method, but whether to perform a biopsy before surgery still remain controversy. Some new technique still has an unknown prospect for the treatment such as radiofrequency ablation.
Bone Neoplasms ; diagnosis ; surgery ; Chondroblastoma ; diagnosis ; surgery ; Humans ; Patella ; surgery

Objective: To study correlation between plasma mitochondrial coupling factor-6 (MCF-6) level in coronary circulation and coronary stenotic degree in CHD patients. Methods: A total of 64 CHD patients were selected as CHD group, and they were further divided into single-vessel group, double-vessel group and multi-vessel coronary disease group; another 20 cases with normal coronary artery were enrolled as normal control group. Radioimmunoassay method was used to measure plasma MCF-6 concentration in peripheral, coronary sinus and aortic root in each group. Multivariant linear gradual regressive analysis was used to analyze above-mentioned correlation. Results: Compared with normal control group, there was significant increase in plasma MCF-6 concentration in peripheral, aortic root and coronary sinus in CHD patients (P<0.05 all) ；compared with aortic root and peripheral plasma, there was significant increase in MCF-6 concentration [(348±48) pg/ml vs. (340±51) pg/ml vs. (402±56) pg/ml, P<0.01 all] in coronary sinus of CHD group；Compared with single-vessel group, double-vessel group, there were increase in MCF-6 concentration in multi-vessel coronary disease group (P<0.05～0.01); Multivariant linear gradual regressive analysis indicated that Gensini score was significant positively correlated with plasma MCF-6 concentrations in coronary sinus and aortic root (r=0.650, P<0.01; r=0.711, P<0.01). Conclusion: Mitochondrial coupling factor-6 participates in the pathophysiological process of coronary heart disease, which may be an important vasoactive substance during development of coronary heart disease.

Brain Neoplasms ; Humans ; Teratoma ; surgery

Objective To explore the effect of GABA on the bionomics of cholangiocarcinoma cell QBC939. Methods The proliferation of QBC939 cells was investigated by MTT. The telomerase activity of QBC939 ceils was examined by modified PCR-ELISA assay. Transwell cell culture chamber assay in vitro was used to detect the ability of invasion of cholangiocarcinoma QBC939. The expression of matrix metalloproteinase (MMP) mRNA and enzymatic activity of QBC939 cells were detected by reverse transcription polymerase chain reaction(RT-PCR) and gelatin zymography, respectively. Results GABA at all tested concentration inhibited the growth and proliferation of QBC939 cells in a time-independent manner, Telomerase activity was inhibited by GABA [(0.82 ± 0.05) vs. (0.56 ± 0.05), (P<0.05)]. GABA inhibited tumor cells' trans-Matrigel ability (at 100 μmol/L GABA, cell's number decreased from 60 ± 10 to 43 ±4, P<0.05) ,and significantly inhibited the activity and expression of MMP(MMP-2、MMP- 9) in a dose dependent way. Conclusions GABA can inhibit the growth、invasion and metastasis of cholangiocarcinoma QBC939. The down-regulation of the activity of Telomerase and MMP may be involved inthis mechanism.

Ductus Arteriosus ; surgery ; Ductus Arteriosus, Patent ; drug therapy ; therapy ; Humans ; Ibuprofen ; administration & dosage ; therapeutic use ; Indomethacin ; administration & dosage ; therapeutic use ; Infant, Low Birth Weight ; Infant, Newborn ; Infant, Premature ; Infant, Premature, Diseases ; drug therapy ; surgery ; therapy ; Ligation ; methods ; Treatment Outcome

Brain Injuries ; nursing ; Custodial Care ; methods ; Humans ; Infant, Newborn ; Spectroscopy, Near-Infrared

Objective To explore the effects of gamma-aminobutyric acid (GABA) on the proliferation, apoptosis and invasion of cholangiocarcinoma cell line QBC_(939). Methods Cholangiocarcinoma cell line QBC_(939) was cultured via routine methods, and was treated with different concentrations of GABA (1, 10,100, 1000 μmol/L, test group) or with complete culture medium (control group). The effects of GABA on the proliferation, apoptosis and invasion of cholangiocarcinoma cell line QBC_(939) were investigated by MTT assay, flow cytometry and Transwell cell culture chamber assay, respectively. The effects of GABA on the activity of matrix metalloproteinase (MMP) secreted by cholangiocarcinoma cells were analyzed by gelatin zymogram, and the content of intracellular cyclic adenosine monophosphate (cAMP) was measured by radioimmunoassay. All data were analyzed by one-way ANOVA. Results As the GABA concentration increased from 1 μmol/L to 1000 μmol/L, the inhibition rate of GABA on cholangiocarcinoma cell line QBC_(939) was increased from 2.6% to 26.8%, and the apoptosis rate also increased from 4.80%±0.04% to 28.03% ±0.01%. The number of cholangiocarcinoma cells that migrated through the Matrigel gel decreased from 60±10 to 43±4, in a dose-dependent manner (F = 7. 883, 83.765, 7. 598, P <0.05). The activity of MMP-2 and MMP-9 was decreased. The content of intracellular cAMP was increased, and there was significant difference in the content of intracellular cAMP between test and control groups (F =9.507, 9.148, 27.418, P < 0.05). Conclusions GABA can inhibit the proliferation and invasion of cholangiocarcinoma cell line QBC_(939) cells by promoting the apoptosis and inhibiting the activity of MMP-2 and MMP-9. The process may be mediated by the information transmission of post-receptor.

OBJECTIVETo investigate the morphology change of stomatognathic muscles after zygomatic plasty combined with mandibular angel plasty.

METHODS3D-CT facial soft tissue measurement was performed pre-operative and at 10 days,3 months post-operatively in 59 cases with prominent malar-complex and mandibular angle. The q test (Newman-Keuls method) was used to analyze the variance.

RESULTSThe cross sectional area of masseter muscle and medial pterygoid muscle were both increased at 10 days, reduced at 3 months post-operatively (P < 0.05). The masseter muscle and medial pterygoid muscle cross sectional areas were (4.73 +/- 0.21) cm2 and (3.24 +/- 0.21) cm2 at anterior nasal spine plane, respectively; the pterygoid muscle cross-sectional area was (1.37 +/- 0.35 ) cm2 at the root of coronoid process plane, showing significant difference, when comparing with those before operation (P < 0.05). Lateral pterygoid muscle and temporal muscle had no statistical difference between the pre-and 10 days post-operatively(P > 0.05), however, the temporal muscle was reduced while the lateral pterygoid muscle was increased at 3 months post-operatively. The temporal muscle cross-sectional area was(2.35 + 0.25) cm2 at coronoid process plane; the temporal muscle and lateral pterygoid muscle cross-sectional areas were (1.00 +/- 0.16) cm2 and (3.54 +/- 0.61) cm2 at the root of coronoid process plane, which were significantly different from those before operation (P < 0.05 ).

CONCLUSIONSBecause of osteotomy, muscles attached position are changed in the short term after zygomatic plasty combined with mandibular angel plasty. Masseter muscle and medial pterygoid muscle are inevitably injuried during the operation. With the postoperative recovery, muscles have adaptive changes which reduced compared with those before operation after their reattachment. Zygomatic plasty can cause temporal muscle atrophy;while the lateral pterygoid muscle is rarely involved, the cross sectional area had no statistical difference between the pre- and 10 days post-operative, and the cross sectional area increase at 3 months post-operatively may be due to a compensational enlargement.

Female ; Follow-Up Studies ; Humans ; Male ; Mandible ; surgery ; Masseter Muscle ; anatomy & histology ; Osteotomy ; Postoperative Period ; Pterygoid Muscles ; anatomy & histology ; Stomatognathic System ; anatomy & histology ; Temporal Muscle ; anatomy & histology ; Zygoma ; surgery

Objective To study the function of the laparoscope in abdominal trauma diagnosis and treatment.Method To use laparoscope in diagnosis and treatment for 20 cases abdominal trauma.Result 11 cases avoided the operation of the open abdomin,7 cases got treatment under the laparoscope;5 cases avoided the negative exploration.Conclusion Laparoscope can be used to clear the diagnosis.avoid negative exploration,treat the injury and help operator to choose incision and type of operation.